ISBER 2023 Annual Meeting and Exhibits
ISBER

ISBER 2023 Annual Meeting & Exhibits

Seattle, USA | May 3 - 6, 2023
Virtual | June 6 - 7, 2023

 


Thank you to BSI Systems for their sponsorship of the ISBER 2023 Annual Meeting webpage.

BSI Systems

Registration

Come as you are: Building Biobanking Bridges

Biobanking science and practice is a multidisciplinary system integrated with many dynamic fields, including but not limited to, biobanking research, technology, management, policy, regulation, economics, industry, politics, security, quality, and ethical-religious-legal-cultural-social issues. Interaction and communication among the boundaries of these fields are critical and indispensable for the biobanking success and this is central to the theme of the ISBER 2023 Annual Meeting - Come As You Are: Building Biobanking Bridges.

The Co-Chairs, Drs. Anusha Hettiaratchi (Australia), Birendra Kumar Yadav (India), and Dayong Gao (USA), warmly welcome you to join the ISBER 2023 to contribute your expertise, wisdom, and experience around this central theme. Additionally, the meeting attendees may wish to schedule other opportunities on their own to visit the world-class research institutions and industrial headquarters, including University of Washington, Fred Hutchinson Cancer Research Center, Boeing, Microsoft, Amazon, Costco, Starbucks, T-Mobile, etc., and to enjoy the three amazing US National Parks in Washington State. ISBER is working to schedule a site visit at a local biobank for delegates.

"I attended the meeting for education purpose[s] as well as to get networking opportunities. This meeting was an eye-opener for me in biobanking development and having time to connect with biobankers from all over the world was one of the special moments in my life..."

IMPORTANT INFORMATION

Registration Type
Onsite
Full Conference - In-Person
$1055 Member
$1355 Non-Member
Student/Tech - In-Person
$600 Member*
$800 Non-Member
One Day Pass - In-Person
$500 Member
$700 Non-Member
Virtual Only
$515 Member
$640 Non-Member
Virtual Only - Student/Technician
$330 Member
$430 Non-Member

In-Person Registration: This registration type is for individuals who will attend the in-person meeting in Seattle, USA from May 3-6, 2023. All in-person delegates will also have access to the virtual meeting platform to continue to access session recordings, abstract presentations, and exhibit booths.

Virtual Only Registration: This registration type is for individuals who wish to attend the virtual portion of the meeting only, scheduled for June 6-7, 2023. If you are attending in-person, you are automatically registered for the virtual event as well and do not need to purchase the virtual-only registration.

*If you are not a current ISBER student/technician member, please submit proof of your student status or a letter from your employer to info@isber.org to receive the student/technician rate.

Low and Middle Income Countries (LMICs):

Delegates in countries identified by the World Bank as Low and Lower-Middle Income are eligible for a 50% discount. Delegates in countries identified as Upper-Middle Income are eligible for a 25% discount. If you are eligible to receive a discount please contact info@isber.org.

To confirm the income classification for your country, please click here.

Please note that if you are also a technician or student, you will receive only the LMIC discount or the technician/student discount, whichever is higher.



We will continue to add our invited speakers to this area as we finalize the meeting program.

Ahmed Samir Abdelhafiz, National Cancer Institute, Cairo University, Egypt

Dr Ahmed Abdelhafiz is a graduate of the Faculty of Medicine, Cairo University. He received his MSc and PhD degrees from the same university. He is currently a hematopathology consultant at the Egyptian NCI, and Shefa Al-Orman oncology hospital. His major interest is hematological malignancies, with a special focus on leukemia. Dr Abdelhafiz joined the biobanking field in 2014. He has published several articles in different biobanking aspects. He is a member of the ISBER education and training committee, ISBER 2022 program committee, and the chair of ISBER meeting workshop review task force.

 

 

Jason Acker, University of Alberta, Canada

Dr. Jason Acker is the Senior Development Scientist with the Canadian Blood Services and a Professor in the Department of Laboratory Medicine and Pathology at the University of Alberta. His research focuses on understanding the response of cells, tissues and organs to ex vivo storage and the development of methods for their preservation and use as therapeutic products. Dr. Acker is the past-president and a Fellow of the Society for Cryobiology and is actively involved in consulting with and advising companies and organizations developing biobanking and cell therapy programs.

 

 

Zanfina Ademi, Monash University, Faculty of Pharmacy and Pharmaceutical Sciences, Australia

Dr. Zanfina Ademi is a Professor of Health Economics, at the Faculty of Pharmacy and Pharmaceutical Sciences, Monash University. She leads a program of research around prevention of diseases and population genomics. She specialises in Health Technology Assessments, economic evaluations alongside clinical trials and registries and decision health economic modelling. She has worked in Australia, Finland and Switzerland, leading funded research projects that have provided evidence on cost-effectiveness and return on investment enabling key decision-makers to enact effective healthcare funding.

 

 

Violeta Argudo-Portal, University of Barcelona, Spain

Violeta Argudo-Portal is a postdoctoral fellow in the Social Anthropology Department at the University of Barcelona. Her research revolves around the study of biomedical knowledge production and life sciences infrastructures. She earned her Ph.D. in Science and Technology Studies with the thesis, “Biomedicine in the making: a qualitative study about biobanks as infrastructures for biomedical research.” As a social scientist, she is interested in studying biobanks from a qualitative approach and fostering inquiries on biobanking as a way to explore anthropological problems.

 

 

Saidou Balam, University of Science, Technology, and Technology of Bamako (USTTB), Mali

Dr. Saidou Balam is an Associate Researcher at the University Hospital of Regensburg (UKR), Germany. He is an associate professor of immunology at the University of Science, Technology, and Technology of Bamako (USTTB), Mali. From 2007-2012, Dr. Balam was a research assistant and later obtained his Ph.D. at the University of Lausanne, Switzerland. Dr. Balam obtained his MD in 2006 at the University of Bamako, Mali. His interested in alloimmunity, infectious immunology, and vaccines. The establishment of a biobank in Mali is one of his priorities.

 

 

Kirk Broders, USDA ARS, USA

Dr. Kirk Broders joined the United States Department of Agriculture – Agricultural Research Service Culture Collection in Peoria, Illinois as the director and curator in August 2020. Since joining the ARS Culture Collection, much of his focus has been on molecular characterization of strains in the collection and improving public access to strains and data. Prior to joining the ARS Culture Collection Dr. Broders led fungal ecology and evolution research groups at the Smithsonian Tropical Research Institute, Colorado State University, and the University of New Hampshire.

 

 

Yunxin Chen, Oncology Precision Medicine, Bayer Pharma, China

Dr. Chen has about 15 years experiences in the field of tumor pathology and biomarker study. He obtained his Pathology degree from Peking Union Medical College in 2008 and also acted as a visiting scientist in ADARC from 2006 to 2007. Since 2008, he worked as a pathologist at department of pathology in Peking University People’s Hospital. Since 2015, he joined the industry for drug development. Currently, he acted as director of oncology precision medicine in Bayer and is responsible for clinical biomarker and CDx development from phase I to III.

 

 

Eng Chon Boon, National University Health System, Singapore

Dr Eng Chon Boon is the co-lead of the Cancer Databases and Tissues Banks platform of the Singapore Translational Cancer Consortium. He is also the director for the Tissue Repository, National University Hospital (NUH), and runs the Hospital-based Cancer Registry (HCR) at the National University Cancer Institute (NCIS). He is also the non-executive director of Cryomics Pte. Ltd., a biobank start-up based in Singapore. He holds a PhD in Molecular Biology and a MSc in Supply Chain Management.

 

 

Graham Colditz, Washington University School of Medicine, USA

Dr. Colditz, became committed to disease prevention during his medical training, University of Queensland, Australia. Now, he is an internationally recognized expert on the causes and prevention of chronic disease, particularly breast cancer. He has worked to build blood and pathology repositories through his research career. At the Siteman Cancer Center since 2006, he leads a range of studies, many focused on reducing health inequities in Siteman’s broader catchment area. These include an NCI P50 Implementation Science Center addressing disparities in our catchment.

 

 

Segun Fatumo, London School of Hygiene and Tropical Medicine, United Kingdom

Dr. Segun Fatumo is an Associate Professor of Genetic Epidemiology and Bioinformatics at the MRC/UVRI Uganda and London School of Hygiene and Tropical Medicine (LSHTM) in the UK. He leads The African Computational Genomics (TACG) Research group at the MRC/UVRI and LSHTM Uganda Research Unit. Dr Fatumo’s research broadly focuses on the genetic impact of non-communicable diseases in Africa, with particular interest in assessing the impact of genetic variation on kidney function, diabetes, lipid metabolism and a range of cardiovascular diseases.

 

 

Kirstin Goldring, AstraZeneca, United Kingdom

Kirstin joined AstraZeneca in January 2015 in the role of Principal Scientist: Human Biological Sample Governance and Strategy. Kirstin works with the biobanks globally to ensure that AstraZeneca scientists can access the samples and data that they need in a compliant way. Kirstin chairs the HBS Governance Council. Kirstin is now Leads the AstraZeneca HBS Compliance and Governance team, supporting compliance is use of HBS across the business.

 

 

Debra Jaramilla, Cornell Veterinary Biobank, USA

Ms. Debra Jaramilla is the Marketing and Communications Manager for the Cornell Veterinary Biobank. She has over 15 years of experience in managing and directing roles at several private sector companies. Her skills and expertise in strategic and product marketing, content creation, and social media play a fundamental role in driving business growth, sustainability, and brand awareness. Ms. Jaramilla is certified in Pragmatic, Demand and Portfolio Marketing. She holds a Bachelor of Science in Business with a minor in Communications from California State University, Dominguez Hills.

 

 

Anthony Larsson, Stockholm Chamber of Commerce, Sweden

Anthony Larsson (Ph.D.) is an author, editor and researcher. He is currently serves as Research Fellow at the Stockholm Chamber of Commerce, Sweden. His publications mainly focus on innovation management, digitalisation, futures studies and scientific controversies.

 

 

Jairam Lingappa, University of Washington, USA

Dr. Lingappa received his BA from Swarthmore College, PhD from Harvard University, and an MD from the University of California, San Francisco. He completed a pediatric residency, and Infectious Diseases fellowship at the University of Washington (UW); and was a disease detective and medical epidemiologist at the CDC. He joined the faculty at the UW in 2004 running HIV clinical trials and translational research studies on genomics and HIV. He is currently a Professor of Global Health, Medicine, and Pediatrics, and Associate Director of the International Clinical Research Center at the UW.

 

 

Amanda Moors, National Inst of Standards & Technology, USA

Amanda Moors serves as the Program Coordinator for the Biospecimen Science Group at the National Institute of Standards & Technology. She oversees the day-to-day operations inside the NIST Biorepository, ensures safety measures are in place, and with her Group, maintains a bank of monitored liquid nitrogen vapor-phase and mechanical freezers. Amanda collaborates with partner agencies to develop and implement standardized collection procedures to efficiently collect, transport, and ship samples to researchers during field work.

 

 

Duong Cong Nguyen, Viet Duc University Hospital, Vietnam

Dr. Nguyen is working at the Viet Duc Tissue Bank at the Viet Duc University Hospital, the largest surgery center in Vietnam. He received his medical degree, Master's degree in Histology & Embryology from Hanoi Medical University. His research interest focus on histopathological preservation. Some of the issues he researched are the structure of the heart valve of pig cryopreserved in medium without FBS; Evaluation of the microstructure and tensile strength of the cryopreserved porcine heart valve; Evaluation of the cryopreservation cranial bone flaps, human tendon allograft.

Ziath

Alison Parry-Jones, Wales Cancer Biobank, United Kingdom

Alison Parry-Jones is the Operations Director of the Wales Cancer Biobank in Cardiff, UK. Her background is in analytical chemistry and before moving into project management she worked in bioanalytical laboratories. Her interest in the legal and ethics issues within biobanking led her to complete an MA in Medical Ethics and Law in 2012.

She is the President Elect for ISBER and is a member of the QBRS ASCP working group. She is on the UKAS Biobank Accreditation Steering Group for ISO20387 and is a member of the Scientific Advisory Board for the European ISIDORe consortium.

Ziath

Kerry Powers, Roche Diagnostic Solution, USA

Working in the health care industry for more than 20 years, my career started with Phlebotomy. I moved into to the Anatomic Pathology lab in 2004 where I started as a courier. In 2012, I was awarded a Bachelor's of Science in Molecular biology from Cameron Univeristy. That same year, at the hospital across from the univeristy, I was promoted to Histology Supervisor. In 2016 I was offered a job with Roche Diagnostics Solutions leading the biorepository, and in Dec 2022 I was awarded a Master of Legal Study from the University of Arizona.

Ziath

Bushra Rakha, Pir Mehr Ali Shah Arid Agriculture University Rawalpindi, Pakistan

Dr. Bushra Allah Rakha is currently serving in Department of Zoology, Wildlife and Fisheries at Pir Mehr Ali Shah Arid Agriculture University, Rawalpindi-Pakistan since May, 2007. She is pioneer researcher from Pakistan who developed assisted reproductive technologies for conserving wildlife species. She has won various competitive research grants from national and International funding agencies. Dr. Rakha has been actively participating in International & National Conferences of her area of research.

Ziath

Gabrielle Samuel, King's College London / University of Oxford, United Kingdom

Dr Gabrielle Samuel (Gabby) is a Senior Research Fellow at the Department for Global Health and Social Medicine, King’s College London, UK, and the Wellcome Centre for Human Genetics, Oxford University, UK. She is a social scientist whose research interests relate to the ethical issues associated with big data and AI in the health arena. Her research, which draws mainly on qualitative research methods, has explored issues spanning a range of innovative biotechnologies, including biobanking, genomics and other genetic databases, forensic/health genetic technologies, and AI health technologies.

Ziath

Karine Sargsyan, Cedar Sinai Medical Center, USA

Prof. Dr. Karine Sargsyan is the Scientific Director of Cancer Biobank at Cedars Sinai Medical Center. Life sciences and research enthusiast who does not think outside of the box, because the box does not exist! She previously served as Managing Director for International Biobanking and Education (since 2019), as founding Managing Director of Biobank Graz (Med Uni Graz), and directed it from 2007 to 2019. Karine was the Scientific Director of Competence Center BioPersMed (2009-2011). She actively developed the Biobanking education in Europe and supports all innovation programs in the field.

Ziath

Zhiquan Shu, University of Washington, USA

Dr. Shu is currently an Assistant Professor in the School of Engineering and Technology at the University of Washington Tacoma, the Associate Director of the Center for Cryo-biomedical Engineering and Artificial Organs and an Affiliate Assistant Professor at the University of Washington (Seattle). Dr. Shu received his Ph.D. from the department of Mechanical Engineering at the University of Washington. His research has been focusing on cryobiology, biopreservation, and artificial organs.

Ziath

Paulina Tindana, University of Ghana School of Public Health, Ghana

Dr Paulina Tindana is an Associate Professor and Bioethicist at the Department of Health Policy, Planning and Management, School of Public Health, University of Ghana. Her work focuses on the ethical, social, cultural and policy implications of biomedical research including genetics and genomics studies. She has been an active member of the H3Africa Consortium since 2013 and chaired the Community Engagement Working Group between 2015 to 2018. She is also involved in research ethics capacity building initiatives for researchers and members of research ethics committees in Africa.

Ziath

Rose Upton, University of Newcastle, Australia

Dr Rose Upton is a conservation and reproductive biologist at the University of Newcastle, Australia. Her research focusses on the development and application of assisted reproductive technologies, such as sperm cryopreservation and IVF, to the conservation of wildlife. Rose was recently involved in a project funded by the Australian federal department of Agriculture, Water, and Environment (DAWE) aiming to collect and store cryopreserved sperm from several amphibian species affected by the 2019/20 bushfires.

Ziath

Andres Villegas-Lanau, Neurobanco - Grupo de Neurociencias de Antioquia - Universidad de Antioquia, Colombia

Andrés Villegas-Lanau is a professor at the University of Antioquia and has been for more than 25 years the coordinator of the brain bank (Neurobank) of the Grupo de Neurociencias de Antioquia, which is dedicated to the study of neurodegenerative diseases. With his team, he has developed different protocols to improve the processing and quality of the stored samples. Over time, the Neurobank has achieved a notable improvement in the quantity and quality of the information obtained from its samples.

Ziath

Yana Wang, Takeda, USA

Dr. Yana Wang is currently a Director at Takeda Oncology Cell Therapy Innovation, heading early discovery of NK and Vδ1 γδ T cell platform. Prior to this role, she led the Process Development for CAR-NK platform in CMC. In her 11 years of experience at Takeda, she has held multiple positions in the Oncology R&D organization, ranging from small molecules to biologics and from autologous CAR-T cell therapy to iPS derived γδT cell therapy in both Discovery and CMC. She obtained her PhD, MS and BS in Chemical Engineering from MIT, University of Minnesota and Tsinghua University respectively.

Ziath

Andy Wang, Bayer Healthcare, China

Cheng Andy Wang, Registered Pharmacist and Microbiologist by training, Sr. Director and Head of Biosample Management Asia at Bayer R & D Beijing & Chairman of Bayer China Human Genetic Resources Management Community, with 15 years industry experience on Biosample Management, China Human Genetic Resources Management, Clinical Operation and infection diseases management in China.

Ziath

Brenda Yanak, Clinical Transformation Partners LLC (Former Vice President, BMS), USA

Ms Yanak is a pioneering biopharma executive with over 20 years' experience across Discovery, IT, Innovation, and Clinical Operations at Pfizer, Merck, BMS, IBM and the 2nd largest Central Lab in the world. She led the team that developed the first automated biorepository in the industry (@Pfizer); the first specimen and consent tracking system (@Merck); and most recently built the first enterprise biospecimen, imaging and consent management organization within Clinical Operations at BMS, where she was also responsible for leading the HGRAC Operations Task Force.

Ziath

All individuals who submitted an abstract should have received notice regarding the status of their submission. If you have not received notice, please email info@isber.org

All abstract presenters are invited to carefully review and follow the abstract presentation instructions. Please note all abstract presenters are expected to register for the meeting. If you have not yet done so, please complete your registration as soon as possible.

We encourage all potential delegates to begin the visa application process as early as possible as you may experience significant delays in booking an appointment for your visa application (ISBER has heard from member's that this can take 4-6 months). If you require an invitation letter for your visa application to attend the ISBER 2023 Annual Meeting in Seattle, USA, please submit a visa letter request form at the below link.

Request a Visa Letter

"...In the exhibit hall we could meet different vendors, service providers and brands, which is helpful to have an overview of new products and trends. I could also meet other colleagues from all over the world and exchange ideas, challenges... In general I found the ISBER meeting a very positive experience and I hope to be able to attend in 2023 as well."

 

View the Corporate Opportunities Brochure

 



Current ISBER 2023 Exhibitors:

a2la

A2LA is an internationally recognized accreditation body whose primary mission is to provide comprehensive accreditation services for laboratories, inspection bodies, proficiency testing providers, reference materials producers, and product certification bodies. Assessments are conducted using international standards and field-specific technical requirements developed in cooperation with government and industry. A2LA provides superior customer service and holds to a higher standard.

 

 

Agilent Technologies

Agilent is a leader in life sciences, diagnostics and applied chemical markets. The company provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling customers to gain the insights they seek. Agilent’s expertise and trusted collaboration give them the highest confidence in our solutions.

Agilent Technologies

AltemisLab

Streamline sample storage, identification & handling with AltemisLab.Founded by an experienced team with considerable industry knowledge. AltemisLab utilises this expertise to deliver the highest quality products & exceptional service. Helping customers to map workflows & identify the tools that will realise practical, financial and time saving benefits. The founders of AltemisLab have been working with 2D barcoded tubes since 2000, when this technology was first used by pharaceutical companies

Agilent Technologies

Askion GmbH

ASKION GmbH - your experienced partner for modular biobanking system solutions to handle and store biological material at highest quality standards at temperatures below -185°C. The ASKION C-line® system provides you with a flexible, modularly expandable and fully automatable system approach for all current and future requirements in the field of cryotechnology/biobanking. Our biobank solution guarantees maximum flexibility regarding sample formats and storage configuration.

Agilent Technologies

ATP-Bio

The National Science Foundation Engineering Research Center for Advanced Technologies for the Preservation of Biological Systems (ATP-Bio) aims to stop biological time and radically extend the ability to bank and transport cells, aquatic embryos, tissue, skin, whole organs, microphysiological systems, and whole organisms through a team approach to build advanced biopreservation technologies.

Agilent Technologies

Autoscribe Informatics Inc

Whatever your Biobank Management needs the Matrix Biobank Management System is easily adapted to suit them. Our simple to use graphical configuration tools set Matrix apart from other Biobank software solutions. Autoscribe Informatics™ Matrix Biobank Management System is used by Biobanks around the world. Dual desktop and web applications provide maximum flexibility to work the way you want, in the laboratory, across the internet, even offline. Please visit our booth to discover for yourself.

Agilent Technologies

Avantor

Avantor® is a Fortune 500 company and leading global provider of mission-critical products and services to customers in a variety of science industries including biopharma and healthcare. For the preclinical and clinical trial community, Avantor Services offers a team of associates with a proven track record of excellence. We provide a range of services including custom kitting and clinical trial equipment and ancillary supply solutions. Avantor– we set science in motion to create a better world

Agilent Technologies

Azenta Life Sciences

Azenta Life Sciences provides unrivaled sample exploration and management solutions to help our customers accelerate discovery, development, and delivery to bring impactful breakthroughs and therapies to market faster. We are the global leader in automated compound management for drug discovery, biological storage, and sample processing solutions. Azenta understands the importance of sample integrity and provides a comprehensive range of solutions across our leading capabilities of genomic services, sample repository services (SRS), consumables and instruments, data management and informatics, sample sourcing, and automated ultra-cold storage.

Agilent Technologies

B Medical Systems

Our mission at B Medical Systems is to create technology that helps save lives across the world. With our four decades of industry experience, we have developed a strong reputation as a customer-centric supplier of medical-grade refrigerators, freezers, and transport boxes that deliver the highest performance in terms of safety, efficiency, and reliability. Our portfolio covers a wide range of applications in medical refrigeration, blood management, and vaccine cold chain.

Agilent Technologies

BioFortis, a Q2 Solutions Company

BioFortis, a Q2 Solutions Company, is a leading provider of precision medicine solutions. Its flagship product, Labmatrix®, is a web-based database application that addresses scientific needs in clinical trial sample and consent tracking, study-subject and biospecimen management, and collaborative clinical and translational research programs.

BioFortis, a Q2 Solutions Company

BioLife Solutions

BioLife Solutions is a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy and broader biopharma markets. Our tools portfolio includes our proprietary CryoStor® and HypoThermosol® biopreservation media for shipping and storage, the ThawSTAR® family of automated, water-free thawing products, evo® cold chain management system, high capacity cryogenic storage freezers, Stirling Ultracold mechanical freezers, SciSafe biologic storage services, and Sexton Biotechnologies cell processing tools.

BioFortis, a Q2 Solutions Company

Bluechiip Limited

Bluechiip offers the only advanced sample management solution on the market that can provide reliable identification and temperature sensing capabilities in cryogenic environments. With the global market leading to ever increasing values for critical samples and therapies, our solution provides confidence in every sample/asset by allowing users to have full chain custody with our BLuechiip Enabled Sample Storage, Readers and Sample Management Software.

BioFortis, a Q2 Solutions Company

Bruker

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma.

BioFortis, a Q2 Solutions Company

BSI Systems

BBSI Systems (BSI, BioShare, and SRL Advantage) is a collection of specimen inventory and resource management products that provide workflow, inventory, and location tracking services for your facility. BSI manages your biobank with a validated software that tracks the complete life cycle of specimens within your repository. BioShare is a web platform for sharing specimens and datasets across a research community. SRL Advantage can aid researchers to locate specimens across a biobanking network.

BioFortis, a Q2 Solutions Company

celltrio

Celltrio offers fully automated solutions for cell line development. The solutions scale from automating specific tasks to fully automating cell culturing, harvesting, and cryogenic storage in one end-to-end system. Celltrio manufactures a complete line of high-quality, secure robotic cryogenic freezers, manual cryogenic freezers, dewars, and shippers for the life sciences, health care, and animal husbandry markets.

celltrio

CloudLIMS.com

CloudLIMS.com offers a secure, in the cloud, SaaS LIMS with zero upfront cost purpose-built for biobanks. CloudLIMS offers complimentary services, including technical support, automatic product upgrades, legacy data migration, product configuration, automatic data backups, and secure data access. CloudLIMS helps biobanks manage samples and metadata, automate and streamline workflows, meet compliance and follow best practices such as ISO 20387:2018, EU GDPR, HIPAA, and ISBER Best Practices.

celltrio

College of American Pathologists

As the world™s leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. The CAP Biorepository Accreditation Program aims to improve the quality and consistency of biorepositories, drawing on best practices from ISBER, NCI, OECD, CMS, and its own accreditation program. Learn more at cap.org.

College of American Pathologists

Cryoport Systems

Cryoport Systems is the market leader in globally integrated temperature-controlled supply chain solutions for critical, irreplaceable products and materials in the life sciences industry. We are already trusted to support over 625 active clinical trials and leading commercial products worldwide - delivering unparalleled, integrated supply chain services for products, therapies and treatments requiring unique, specialized temperature-controlled management.

Cryoport Systems

Cryotherm

Cryotherm as a leading supplier of storage, transfer & transport systems, has been a renowned manufacturer of products and services for cryogenic technology for nearly 60 years. The network-compatible BIOSAFE® systems are biorepository freezers, available with narrow and wide neck openings, for the preservation and long-term storage of biological and medical samples. You always keep the overview with the BIOSAFE ® i-track for your comfortable sample management!

Cryotherm

DiData

DiData is a ready-to-use and flexible web-based platform to integrate your scientific data such as clinical projects, laboratory, biobanks, and more

DiData

Ellab Inc.

Ellab provides world-leading validation, monitoring and calibration solutions and services, as well as GMP consulting, to life science and food manufacturing companies across the globe – allowing us to build confidence in consumer safety together.

Ellab Inc.

FARRAR

Powered by Trane Technologies, Farrar Scientific and Industrial Refrigeration bring industry-leading technology and applications, specialized engineers and technicians, and customer relationships with major pharmaceutical and biopharmaceutical companies around the world.

Farrar Scientific / Trane Technologies

Freezerworks

Configurable software solutions for biological sample and study management. Track sample data across multiple freezers while managing workflow. Flexible and user-friendly, Freezerworks puts the laboratory in control with easy-to-build fields, screens, and reports. Safeguard data with comprehensive security features, 21 CFR part 11 compliance, and cryogenic-safe barcode labeling.

Freezerworks

GenVault Biorepository

Our state-of-the-art facilities were purpose-built by industry experts to be one of the nation™s most secure commercial biorepositories. With our secure biostorage solutions, lab transport services, and expert team, you can spend less time worrying about sample preservation for future generations and more time innovating. Also, we offer GenVault Transportation Services to laboratories across the United States offering freezer and refrigerated moving solutions.

 

 

Greiner Bio-One

A world-renowned partner for OEM, drug discovery, & diagnostics, Greiner Bio-One integrates injection-molding expertise with scientific innovation. Precision engineering, premium materials and advanced surfaces are employed to manufacture an extensive platform for state-of-the-art methodologies in HTS, Immunology, Cell Culture & Cell Therapy. For sample storage, GBO combines more than 30 years experience with the latest technology to offer a comprehensive Cryo.s & Biobanking product portfolio.

Haier Biomedical

Operating globally, Haier Biomedical, the world™s leading complete biomedical life science cold chain provider, has solutions storage for biological sample banks, blood safety, vaccine safety, medical supplies and reagent safety covering the full range of -196°C to +8°C.

Haier Biomedical

Hamilton

Hamilton is a global leader in the design and manufacturing of automated storage systems. By safeguarding the integrity of even the most precious samples, our solutions and expert knowledge empower researchers to reach new heights of laboratory efficiency. Our sample storage solutions, benchtop devices, and consumables are designed for sample integrity, flexibility, and reliability for life science applications.

Hamilton

IC Biomedical

Capitalizing on a 65-year legacy of cold chain storage and transport technology, IC Biomedical is bringing new life to the cryogenic equipment market. IC Biomedical is building the highest-quality cryogenic storage and transport systems for the global biomedical research and development, healthcare, biorepository, pharmaceutical, biotechnology, IVF and animal husbandry semen markets. All products are manufactured in our ISO 13485:2016-certified manufacturing facility in Cartersville, Georgia.

Hamilton

iSpecimen

iSpecimen offers an online marketplace for human biospecimens, connecting life scientists in commercial and non-profit organizations with healthcare providers that have access to patients and specimens needed for medical discovery. Proprietary, cloud-based technology enables scientists to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers, and other healthcare organizations.

iSpecimen

Kaye - a Subsidiary of Amphenol

For more than 60 years, Kaye has been at the forefront of high accuracy process measurement. For applications from thermal process validation and environmental monitoring to sensor calibration, Kaye technology has provided the most accurate and user-friendly measuring systems available in the market today. Kaye equipment has become the standard for helping customers increase validation process efficiency and document the results.

Kaye - a Subsidiary of Amphenol

LabVantage Solutions, Inc.

LabVantage is the recognized leader in enterprise laboratory software solutions, LabVantage Biobank is pre-configured to address all aspects of biorepository management so you can collect, process, store, and distribute well-annotated, high-quality biospecimens. It is 100% browser-based to support hundreds of concurrent users. Deployed on-premise, via the cloud, or SaaS, it seamlessly interfaces with instruments and other enterprise systems – enabling true digital transformation.

LabVantage Solutions, Inc

Liconic USA

LiCONiC specializes in the design and manufacture of automated sample storage solutions used in laboratories and applications with special climate requirements. We are experts in sample management and tracking for the biorepository, blood banking, and compound storage markets. Our 30 years of leadership in this field has led to an installation base of several thousands of systems in operation worldwide. Liconic's built-for-purpose approach provides users with state-of-the-art storage solutions.

LabVantage Solutions, Inc

LVL technologies GmbH & Co. KG

LVL have been offering consumables for laboratory automation and automated liquid handling since 1986. The main focus of our product range is sample storage solutions in standardized SBS format. Deep well plates, reservoirs, microtiter plates, alphanumeric coded tube rack system and our LVL´D UP 2D Tube Rack System SAFE® in 96/48/24 format. The working volume of the tubes ranges from 200μl to 8ml. The associated infrastructure, such as readers and cappers, are also part of our product range.

LabVantage Solutions, Inc

Modul-Bio

Modul-Bio specialises in IT solutions for biological sample management, implementing barcode systems, Biobank Information Management Systems (BIMS) and collaborative tools for tracking, managing and sharing biospecimen collections. We deploy software dedicated to biobanking for Biological Resource Centres, national cohort projects, biotech companies and biorepositories.

LabVantage Solutions, Inc

MVE BIOLOGICAL SOLUTIONS

MVE Biological Solutions is the leading global manufacturer of vacuum-insulated products and cryogenic systems. For over 50 years, we set the standard for storage of biological materials at low temperatures. MVE is the preferred brand for cryogenic equipment in a variety of application areas including bio-pharma cell and gene therapies, storage of cord blood and stem cells, medical research facilities, government institutions, IVF centers, hospitals and clinics, and animal husbandry and livestock.

 

Olink Proteomics

Olink is dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. Olink provides a platform of products and services which are deployed across major biopharmaceutical companies and leading clinical and academic institutions to deepen the understanding of real-time human biology and drive 21st century healthcare through actionable and impactful science.

Olink Proteomics

OpenSpecimen Biobanking LIMS

OpenSpecimen Biobanking LIMS is used in 80+ academic research centers across 20+ countries. Its customers include Johns Hopkins, Emory, Univ of Pittsburgh, Univ of Texas, Oxford, Cambridge, Univ of New South Wales, Univ of Melbourne, etc. OpenSpecimen is highly configurable to meet the diverse needs of the biobanking domain. Biobanks can use OpenSpecimen to track biospecimens from collection to utilization, collect high-quality disease/study-specific annotations, and powerful reporting.

OpenSpecimen Biobanking LIMS

OriginCell Instruments

A leading innovator of automatic sample storage technologies, OriginCell is committed to the R & D and manufacturing of advanced automatic cryogenic and ultra-low temperature sample storage systems. Stemmed from the in-depth knowledge of cryogenic freezing and cell preparation, and with a strong multidisciplinary team of scientists and engineers, OriginCell provides one-stop solution for automatic and intelligent biobanks.

OpenSpecimen Biobanking LIMS

phasetwo

phasetwo offers a full spectrum of cold storage products that have been re-engineered with a user-centric design. Our next generation solutions enhance the user experience by focusing on present day needs, rather than historic and outdated designs.

OpenSpecimen Biobanking LIMS

PHC Corporation of North America

PHC Corporation of North America (PHCNA) headquartered in Wood Dale, IL, manufactures and markets PHCbi brand laboratory equipment. For more than 50 years, PHCNA has met the needs of pharmaceutical, biotechnology, hospital/clinical, and industrial customers through our highly-reliable and innovative laboratory equipment. Our PHCbi brand products include ultra-low temperature freezers, cryogenic and biomedical freezers, high-performance refrigerators and CO2 and multigas incubators.

OpenSpecimen Biobanking LIMS

Rees Scientific

Since 1982, Rees Scientific has been the most compliant continuous environmental monitoring system in the industry. Our system can monitor the temperature of any cold storage (refrigerators, freezers, ultra-low freezers) from +1,300 to -196 °C. We monitor equipment and parameters such as temperature, humidity, light, differential pressure and more.

Rees Scientific

StageBio

StageBio is a leading international provider of GLP-compliant research, preclinical and clinical histology, pathology and specimen archiving services for the biopharmaceutical, medical device and contract research industries. At StageBio we have a team of board-certified veterinary pathologists and more than 100 laboratory technicians on staff supporting our unified commitment to quality, scientific integrity and client satisfaction. Learn more at www.stagebio.com.

StageBio

Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support.

Thermo Fisher Scientific

TubeWriter

TubeWriter provides the fastest and most flexible sample identification solutions for the life science industry. Any size tube or labware can be printed including PCR strips, 2ml cryovials, caps, 50ml conical tubes, and microplates.

Ziath

Zymo Research Corp

Zymo Research is a globally established biotechnology company and industry leader in the fields of epigenetics, microbiomics, and the emerging Next-Gen Sequencing space. Even with the most technologically advanced products in the industry, everything is driven by the fundamental belief that & the beauty of science is to make things simple.

Ziath

Task Force Responsibilities:

  1. Creating the Program for the ISBER Annual Meeting
  2. Communicating with speakers who have been invited to the annual meeting, organizing the review of submitted abstracts, recommending and inviting co-chairs for each session of the annual meeting, and arranging various other details associated with the meeting

Task Force Co-Chairs:

Anusha Hettiaratchi, PhD
University of New South Wales
Sydney, Australia
Dayong Gao, PhD

University of Washington
Seattle, USA
Birendra Kumar Yadav, PhD, MBA
National Liver Disease Biobank, Institute of Liver and Biliary Sciences
New Delhi, India

Committee Members:

Ahmed Abdelhafiz
National Cancer Institute
Cairo, Egypt

Jennifer Byrne, BSc (Hons), PhD
NSW Health Statewide Biobank
Camperdown, Australia

Helena Ellis,
Biobanking Without Borders, LLC
Durham, United States

Debra Leiolani Garcia BS, MPA
Independent Consultant
San Mateo, United States

Cassandra Griffin,
Hunter Cancer Biobank – University of Newcastle
New Lambton Heights, Australia

Azra Hasan,
Memorial University of Newfoundland
St. John's, Canada

Kouame Ambroise Kintossou BS, MPA
Institut Pasteur Cote d'Ivoire
Abidjan, Côte d'Ivoire

Anna Michalska-Falkowska,
Medical University of Bialystok
Bialystok, Poland

Wayne Ng, BSc, MSc, PhD
Victorian Cancer Bank
Melbourne, Australia

Izabela Piotrowska, PhD
Boehringer Ingelheim
Ingelheim, Germany

Jumi Popoola, MSc, PhD
54gene
Lagos, Nigeria

V Krishnan Ramanujan, PhD, MS
Cedars Sinai
Los Angeles, United States

Shen Ren,
University of Washington
Seattle, United States

Mandy Riffel, BS, MBA
Dataworks Development, Inc. (Freezerworks)
Mountlake Terrace, United States

Karine Sargsyan,
Medical University of Graz
Graz, Austria

Billy Schleif, MS, MT
Johns Hopkins All Children's Pediatric Biorepository
St. Petersburg, United States

Rosy Singh,
Barrow Neurological Institute
Phoenix, United States

Lalita Wadhwa, PhD
Texas Children's Hospital
Houston, United States

Register Now